Understanding heterogeneity in meta-analysis: the role of meta-regression

被引:363
作者
Baker, W. L. [1 ,2 ]
White, C. Michael [1 ,2 ]
Cappelleri, J. C. [3 ]
Kluger, J. [1 ,2 ]
Coleman, C. I. [1 ,2 ]
机构
[1] Univ Connecticut, Storrs, CT USA
[2] Hartford Hosp, Hartford, CT 06115 USA
[3] Pfizer Inc, Biostat, New London, CT USA
关键词
CUMULATIVE METAANALYSIS; PATIENT-LEVEL; TRIALS; INDIVIDUALS; METHODOLOGY; PRAVASTATIN; MEDICINE; RISK;
D O I
10.1111/j.1742-1241.2009.02168.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P>Background: Meta-regression has grown in popularity in recent years, paralleling the increasing numbers of systematic reviews and meta-analysis published in the biomedical literature. However, many clinicians and decision-makers may be unfamiliar with the underlying principles and assumptions made within meta-regression leading to incorrect interpretation of their results. Aims: This paper reviews the appropriate use and interpretation of meta-regression in the medical literature, including cautions and caveats to its use. Materials & Methods: A literature search of MEDLINE (OVID) from 1966-February 2009 was conducted to identify literature relevant to the topic of heterogeneity and/or meta-regression in systematic reviews and meta-analysis. Results: Meta-analysis, a statistical method of pooling data from studies included in a systematic review, is often compromised by heterogeneity of its results. This could include clinical, methodological or statistical heterogeneity. Meta-regression, said to be a merging of meta-analytic and linear regression principles, is a more sophisticated tool for exploring heterogeneity. It aims to discern whether a linear relationship exists between an outcome measure and on or more covariates. The associations found in a meta-regression should be considered hypothesis generating and not regarded as proof of causality. Conclusions: The current review will enable clinicians and healthcare decision-makers to appropriately interpret the results of meta-regression when used within the constructs of a systematic review, and be able to extend it to their clinical practice.
引用
收藏
页码:1426 / 1434
页数:9
相关论文
共 43 条
[1]  
Abarca J, 2000, FORMULARY, V35, P832
[2]   Effect of perioperative corticosteroid use on the incidence of postcardiothoracic surgery atrial fibrillation and length of stay [J].
Baker, William L. ;
White, C. Michael ;
Kluger, Jeffrey ;
Denowitz, Aaron ;
Konecny, Christopher P. ;
Coleman, Craig I. .
HEART RHYTHM, 2007, 4 (04) :461-468
[3]  
Berkey CS, 1998, STAT MED, V17, P2537, DOI 10.1002/(SICI)1097-0258(19981130)17:22<2537::AID-SIM953>3.0.CO
[4]  
2-C
[5]   A RANDOM-EFFECTS REGRESSION-MODEL FOR METAANALYSIS [J].
BERKEY, CS ;
HOAGLIN, DC ;
MOSTELLER, F ;
COLDITZ, GA .
STATISTICS IN MEDICINE, 1995, 14 (04) :395-411
[6]   Individual patient- versus group-level data meta-regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly head [J].
Berlin, JA ;
Santanna, J ;
Schmid, CH ;
Szczech, LA ;
Feldman, HI .
STATISTICS IN MEDICINE, 2002, 21 (03) :371-387
[7]   Does pravastatin promote cancer in elderly patients? A meta-analysis [J].
Bonovas, Stefanos ;
Sitaras, Nikolaos M. .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2007, 176 (05) :649-654
[8]   Chronic hepatitis C:: Interferon retreatment of relapsers.: A meta-analysis of individual patient data [J].
Cammà, C ;
Giunta, M ;
Chemello, L ;
Alberti, A ;
Toyoda, H ;
Trepo, C ;
Marcellin, P ;
Zahm, F ;
Schalm, S ;
Craxi, A .
HEPATOLOGY, 1999, 30 (03) :801-807
[9]  
CAPPELLERI JC, 2003, ENCY BIOPHARMACEUTIC, P586
[10]   Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data [J].
Chaturvedi, N .
ANNALS OF INTERNAL MEDICINE, 2001, 134 (05) :370-379